Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Estrogen-Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients.

van Aerts RMM, Bernts LHP, Gevers TJG, Kievit W, Koopmans L, Nieboer TE, Nevens F, Drenth JPH.

Clin Pharmacol Ther. 2019 Jun 17. doi: 10.1002/cpt.1553. [Epub ahead of print]

PMID:
31206615
2.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH; DIPAK-1 Investigators.

Gastroenterology. 2019 Aug;157(2):481-491.e7. doi: 10.1053/j.gastro.2019.04.018. Epub 2019 Apr 22.

PMID:
31022403
3.

Three-D Wide Faces (3DWF): Facial Landmark Detection and 3D Reconstruction over a New RGB⁻D Multi-Camera Dataset.

Quintana M, Karaoglu S, Alvarez F, Menendez JM, Gevers T.

Sensors (Basel). 2019 Mar 4;19(5). pii: E1103. doi: 10.3390/s19051103.

4.

Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.

Pape S, Gevers TJG, Belias M, Mustafajev IF, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Hartl J, Schramm C, Lohse AW, Taubert R, Jaeckel E, Manns MP, Papp M, Stickel F, Heneghan MA, Drenth JPH.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2068-2075.e2. doi: 10.1016/j.cgh.2018.12.035. Epub 2019 Jan 6.

PMID:
30625402
5.

Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.

Neijenhuis MK, Wijnands TFM, Kievit W, Ronot M, Gevers TJG, Drenth JPH.

Eur Radiol. 2019 Jun;29(6):3062-3068. doi: 10.1007/s00330-018-5851-y. Epub 2018 Dec 12.

6.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Meijer E, Visser FW, van Aerts RMM, Blijdorp CJ, Casteleijn NF, D'Agnolo HMA, Dekker SEI, Drenth JPH, de Fijter JW, van Gastel MDA, Gevers TJ, Lantinga MA, Losekoot M, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Wetzels JF, Zietse R, Gansevoort RT; DIPAK-1 Investigators.

JAMA. 2018 Nov 20;320(19):2010-2019. doi: 10.1001/jama.2018.15870.

7.

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues.

van Aerts RMM, Kolkman M, Kievit W, Gevers TJG, Nevens F, Drenth JPH.

Therap Adv Gastroenterol. 2018 Oct 3;11:1756284818804784. doi: 10.1177/1756284818804784. eCollection 2018.

8.

Regression of hepatocellular adenoma after bariatric surgery in severe obese patients.

Gevers TJG, Marcel Spanier BW, Veendrick PB, Vrolijk JM.

Liver Int. 2018 Dec;38(12):2134-2136. doi: 10.1111/liv.13934. Epub 2018 Aug 10.

PMID:
30025198
9.

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts.

Wijnands TF, Schoenemeier B, Potthoff A, Gevers TJ, Groenewoud H, Gebel MJ, Rifai K, Manns MP, Drenth JP.

United European Gastroenterol J. 2018 Jul;6(6):919-925. doi: 10.1177/2050640618764940. Epub 2018 Mar 8.

10.

Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.

Lantinga MA, de Sévaux RGL, Gevers TJG, Oyen WJG, de Fijter JW, Soonawala D, Zietse R, Salih M, Casteleijn NF, Spithoven EM, Meijer E, Gansevoort RT, Drenth On Behalf Of The Dipak Consortium JPH.

Neth J Med. 2018 Jul;76(5):226-234.

11.

Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.

Neijenhuis M, Gevers TJG, Atwell TD, Gunneson TJ, Schimek AC, Kievit W, Drenth JPH, Kamath PS.

Am J Gastroenterol. 2018 Apr;113(4):567-575. doi: 10.1038/ajg.2018.18. Epub 2018 Mar 20.

PMID:
29557942
12.

Impact of liver volume on polycystic liver disease-related symptoms and quality of life.

Neijenhuis MK, Kievit W, Verheesen SM, D'Agnolo HM, Gevers TJ, Drenth JP.

United European Gastroenterol J. 2018 Feb;6(1):81-88. doi: 10.1177/2050640617705577. Epub 2017 Apr 13.

13.

Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.

Wijnands TFM, Gevers TJG, Lantinga MA, Te Morsche RH, Schultze Kool LJ, Drenth JPH.

Eur Radiol. 2018 Jun;28(6):2682-2689. doi: 10.1007/s00330-017-5205-1. Epub 2018 Jan 9.

14.

The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.

D'Agnolo HMA, Casteleijn NF, Gevers TJG, de Fijter H, van Gastel MDA, Messchendorp AL, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JFM, Zietse R, Gansevoort RT, Drenth JPH.

Am J Nephrol. 2017;46(3):239-248. doi: 10.1159/000479436. Epub 2017 Sep 8.

PMID:
28881341
15.

Point Light Source Position Estimation From RGB-D Images by Learning Surface Attributes.

Karaoglu S, Yang Liu, Gevers T, Smeulders AWM.

IEEE Trans Image Process. 2017 Nov;26(11):5149-5159. doi: 10.1109/TIP.2017.2731619. Epub 2017 Jul 24.

PMID:
28749351
16.

The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.

Neijenhuis MK, Kievit W, Perrone RD, Sloan JA, Erwin P, Murad MH, Gevers TJG, Hogan MC, Drenth JPH.

BMC Nephrol. 2017 May 25;18(1):169. doi: 10.1186/s12882-017-0578-6. Review.

17.

Con-Text: Text Detection for Fine-Grained Object Classification.

Karaoglu S, Tao R, van Gemert JC, Gevers T.

IEEE Trans Image Process. 2017 Aug;26(8):3965-3980. doi: 10.1109/TIP.2017.2707805. Epub 2017 May 24.

PMID:
28541898
18.

Expression-Invariant Age Estimation Using Structured Learning.

Lou Z, Alnajar F, Alvarez JM, Hu N, Gevers T.

IEEE Trans Pattern Anal Mach Intell. 2018 Feb;40(2):365-375. doi: 10.1109/TPAMI.2017.2679739. Epub 2017 Mar 8.

PMID:
28287961
19.

Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic Review.

Wijnands TF, Görtjes AP, Gevers TJ, Jenniskens SF, Kool LJ, Potthoff A, Ronot M, Drenth JP.

AJR Am J Roentgenol. 2017 Jan;208(1):201-207. doi: 10.2214/AJR.16.16130. Epub 2016 Nov 8. Review.

PMID:
27824501
20.

International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection.

Lantinga MA, Darding AJ, de Sévaux RG, Alam A, Bleeker-Rovers CP, Bobot M, Cornec-Le Gall E, Gevers TJ, Hassoun Z, Meijer E, Mrug M, Nevens F, Onuchic LF, Pei Y, Piccoli GB, Pirson Y, Rangan GK, Torra R, Visser FW, Jouret F, Kanaan N, Oyen WJ, Suwabe T, Torres VE, Drenth JP; Delphi collaborators.

Nephron. 2016;134(4):205-214. Epub 2016 Sep 3.

PMID:
27599120
21.

Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients.

Gevers TJ, Burger D, Schipper-Reintjes E, Kooistra MP, Richter C.

Neth J Med. 2016 Jun;74(5):225-7. No abstract available.

22.

In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis.

Lounis N, Vranckx L, Gevers T, Kaniga K, Andries K.

Med Mal Infect. 2016 Jun;46(4):220-5. doi: 10.1016/j.medmal.2016.04.007.

PMID:
27210281
23.

Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.

Wijnands TF, Ronot M, Gevers TJ, Benzimra J, Kool LJ, Vilgrain V, Drenth JP.

Eur Radiol. 2017 Feb;27(2):741-748. doi: 10.1007/s00330-016-4363-x. Epub 2016 May 14.

24.

Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.

Neijenhuis MK, Gevers TJ, Hogan MC, Kamath PS, Wijnands TF, van den Ouweland RC, Edwards ME, Sloan JA, Kievit W, Drenth JP.

Hepatology. 2016 Jul;64(1):151-60. doi: 10.1002/hep.28545. Epub 2016 Apr 15.

25.

Detect2Rank: Combining Object Detectors Using Learning to Rank.

Karaoglu S, Yang Liu, Gevers T.

IEEE Trans Image Process. 2016 Jan;25(1):233-48. doi: 10.1109/TIP.2015.2499702. Epub 2015 Nov 11.

PMID:
26571528
26.

Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysis.

Gevers TJ, Nevens F, Torres VE, Hogan MC, Drenth JP.

Liver Int. 2016 Apr;36(4):595-602. doi: 10.1111/liv.12986. Epub 2015 Nov 9.

27.

Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials.

Neijenhuis MK, Gevers TJ, Nevens F, Hogan MC, Torres VE, Kievit W, Drenth JP.

Aliment Pharmacol Ther. 2015 Sep;42(5):591-8. doi: 10.1111/apt.13301. Epub 2015 Jul 1.

28.

Extracting 3D layout from a single image using global image structures.

Lou Z, Gevers T, Hu N.

IEEE Trans Image Process. 2015 Oct;24(10):3098-108. doi: 10.1109/TIP.2015.2431443. Epub 2015 May 8.

PMID:
25966478
29.
30.

Combining facial dynamics with appearance for age estimation.

Dibeklioglu H, Alnajar F, Ali Salah A, Gevers T.

IEEE Trans Image Process. 2015 Jun;24(6):1928-43. doi: 10.1109/TIP.2015.2412377. Epub 2015 Mar 13.

PMID:
25781877
31.

Antiviral therapy in chronic hepatitis E: a systematic review.

Peters van Ton AM, Gevers TJ, Drenth JP.

J Viral Hepat. 2015 Dec;22(12):965-73. doi: 10.1111/jvh.12403. Epub 2015 Mar 11. Review.

PMID:
25760481
32.

Estimation of sunlight direction using 3D object models.

Liu Y, Gevers T, Li X.

IEEE Trans Image Process. 2015 Mar;24(3):932-42. doi: 10.1109/TIP.2014.2378032. Epub 2014 Dec 22.

PMID:
25546858
33.

Systematic review: the management of hepatic cyst infection.

Lantinga MA, Geudens A, Gevers TJ, Drenth JP.

Aliment Pharmacol Ther. 2015 Feb;41(3):253-61. doi: 10.1111/apt.13047. Epub 2014 Dec 12. Review.

34.

Robustifying descriptor instability using Fisher vectors.

Everts I, van Gemert JC, Mensink T, Gevers T.

IEEE Trans Image Process. 2014 Dec;23(12):5698-706.

PMID:
25373082
35.

Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.

Gevers TJ, Hol JC, Monshouwer R, Dekker HM, Wetzels JF, Drenth JP.

Liver Int. 2015 May;35(5):1607-14. doi: 10.1111/liv.12726. Epub 2014 Dec 1.

PMID:
25369108
36.

A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Casteleijn NF, Visser FW, Drenth JP, Gevers TJ, Groen GJ, Hogan MC, Gansevoort RT; DIPAK Consortium.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv142-53. doi: 10.1093/ndt/gfu073. Review.

37.

Color constancy using 3D scene geometry derived from a single image.

Elfiky N, Gevers T, Gijsenij A, Gonzalez J.

IEEE Trans Image Process. 2014 Sep;23(9):3855-68. doi: 10.1109/TIP.2014.2336545. Epub 2014 Jul 16.

PMID:
25051548
38.

Acquired resistance of Mycobacterium tuberculosis to bedaquiline.

Andries K, Villellas C, Coeck N, Thys K, Gevers T, Vranckx L, Lounis N, de Jong BC, Koul A.

PLoS One. 2014 Jul 10;9(7):e102135. doi: 10.1371/journal.pone.0102135. eCollection 2014.

39.

Diagnostic criteria in renal and hepatic cyst infection.

Lantinga MA, Drenth JP, Gevers TJ.

Nephrol Dial Transplant. 2015 May;30(5):744-51. doi: 10.1093/ndt/gfu227. Epub 2014 Jun 20. Review.

PMID:
24950937
40.

Evaluation of color spatio-temporal interest points for human action recognition.

Everts I, van Gemert JC, Gevers T.

IEEE Trans Image Process. 2014 Apr;23(4):1569-80. doi: 10.1109/TIP.2014.2302677.

PMID:
24577192
41.

Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.

Meijer E, Drenth JP, d'Agnolo H, Casteleijn NF, de Fijter JW, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium.

Am J Kidney Dis. 2014 Mar;63(3):446-55. doi: 10.1053/j.ajkd.2013.10.011. Epub 2013 Dec 15.

42.

Effects of chromatic image statistics on illumination induced color differences.

Lucassen MP, Gevers T, Gijsenij A, Dekker N.

J Opt Soc Am A Opt Image Sci Vis. 2013 Sep 1;30(9):1871-84. doi: 10.1364/JOSAA.30.001871.

PMID:
24323269
43.

Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume.

Wijnands TF, Neijenhuis MK, Kievit W, Nevens F, Hogan MC, Torres VE, Gevers TJ, Drenth JP.

Liver Int. 2014 Nov;34(10):1578-83. doi: 10.1111/liv.12430. Epub 2014 Jan 9.

PMID:
24313956
44.

Evaluation of hepatic cystic lesions.

Lantinga MA, Gevers TJ, Drenth JP.

World J Gastroenterol. 2013 Jun 21;19(23):3543-54. doi: 10.3748/wjg.v19.i23.3543. Review.

45.

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data.

Temmerman F, Gevers T, Ho TA, Vanslembrouck R, Coudyzer W, van Pelt J, Bammens B, Pirson Y, Drenth JP, Nevens F.

Aliment Pharmacol Ther. 2013 Aug;38(4):397-406. doi: 10.1111/apt.12384. Epub 2013 Jun 25.

46.

Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.

Gevers TJ, Inthout J, Caroli A, Ruggenenti P, Hogan MC, Torres VE, Nevens F, Drenth JP.

Gastroenterology. 2013 Aug;145(2):357-65.e1-2. doi: 10.1053/j.gastro.2013.04.055. Epub 2013 May 7.

PMID:
23665274
47.

Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.

Chrispijn M, Gevers TJ, Hol JC, Monshouwer R, Dekker HM, Drenth JP.

J Hepatol. 2013 Jul;59(1):153-9. doi: 10.1016/j.jhep.2013.03.004. Epub 2013 Mar 14.

PMID:
23499726
48.

Diagnosis and management of polycystic liver disease.

Gevers TJ, Drenth JP.

Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):101-8. doi: 10.1038/nrgastro.2012.254. Epub 2013 Jan 8. Review.

PMID:
23296249
49.

Joint attention by gaze interpolation and saliency.

Yücel Z, Salah AA, Meriçli Ç, Meriçli T, Valenti R, Gevers T.

IEEE Trans Cybern. 2013 Jun;43(3):829-42. doi: 10.1109/TSMCB.2012.2216979. Epub 2012 Oct 3.

PMID:
23047879
50.

Accurate eye center location through invariant isocentric patterns.

Valenti R, Gevers T.

IEEE Trans Pattern Anal Mach Intell. 2012 Sep;34(9):1785-98. doi: 10.1109/TPAMI.2011.251.

PMID:
22813958

Supplemental Content

Loading ...
Support Center